Literature DB >> 3137558

Liver involvement in human schistosomiasis mansoni. Assessment by immunological and biochemical markers.

K Zwingenberger1, H Feldmeier, J A Queiroz, J G Siqueira, H F Auto, J E Alencar, U Bienzle.   

Abstract

In 20 patients with hepatic or hepatosplenic schistosomiasis and 82 individuals infected with S. mansoni, but without liver enlargement, serum parameters reflecting the fibrotic process and hemodynamic alterations as well as immunomodulation were examined. Included as controls were 35 age- and sex-matched healthy individuals from the study region in Northeast Brazil. Peripheral blood cholylglycine levels in patients with hepatomegaly, reflecting the spillover of portal blood into the systemic circulation, were elevated 12-fold over values of patients without liver involvement. Procollagen-III-peptide, a cleavage product of collagen synthesis, was elevated in patients with hepatomegaly (P less than 0.001) but normal in uncomplicated cases. Immunomodulation was assessed by in vivo delayed hypersensitivity to recall antigens and by serum beta 2-microglobulin and neopterin, substances released in the context of lymphocyte activation. Neopterin, predominantly a macrophage product, was elevated most strikingly in hepatomegalic cases (P less than 0.001). The possible interrelation between altered immune responses and excess fibrogenesis is discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3137558     DOI: 10.1007/bf00535145

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  24 in total

1.  A quantitative post-mortem study of Schistosomiasis mansoni in man.

Authors:  A W Cheever
Journal:  Am J Trop Med Hyg       Date:  1968-01       Impact factor: 2.345

2.  Chronic human schistosomiasis mansoni. Pathology of the Disse's space.

Authors:  J A Grimaud; R Borojevic
Journal:  Lab Invest       Date:  1977-03       Impact factor: 5.662

Review 3.  The kinetics of hepatosplenic schistosomiasis.

Authors:  K S Warren
Journal:  Semin Liver Dis       Date:  1984-11       Impact factor: 6.115

4.  Radioimmunoassay of serum conjugated cholic acid in hepatic murine schistosomiasis.

Authors:  D M Bolarin
Journal:  Trans R Soc Trop Med Hyg       Date:  1984       Impact factor: 2.184

5.  Clinical recognition of mild hepatic schistosomiasis in an endemic area.

Authors:  M K Mackenjee; H M Coovadia; C H Chutte
Journal:  Trans R Soc Trop Med Hyg       Date:  1984       Impact factor: 2.184

6.  Immunodiagnosis of Schistosomiasis haematobium and schistosomiasis mansoni in man. Application of crude extracts from adult worms and cercariae in the IHA and the ELISA.

Authors:  H Feldmeier; D W Büttner
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1983-09

7.  Study of eosinophilia in relation to serum IgE level and cell mediated immunity (CMI) to soluble egg antigen (SEA) in human schistosomiasis mansoni.

Authors:  S H Khalil; H Khalil; M H Fahmy; M Said; M el Sawy; M Nofal; F Amara; M Taky; J Brock; M Arab
Journal:  Allerg Immunol (Leipz)       Date:  1985

8.  Relationship between intensity of infection and immunomodulation in human schistosomiasis. I. Lymphocyte subpopulations and specific antibody responses.

Authors:  H Feldmeier; G A Gastl; U Poggensee; C Kortmann; A A Daffalla; H H Peter
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

9.  Morphological, histochemical and biochemical observations on the connective tissue matrix of in situ and isolated hepatic granulomas in experimental murine schistosomiasis.

Authors:  L C Junqueira; G S Montes; O M Toledo; P P Joazeiro
Journal:  Ann Trop Med Parasitol       Date:  1986-02

10.  Basement membrane proteins and type III procollagen in murine schistosomiasis.

Authors:  E R Parise; J A Summerfield; E Hahn; K H Wiedmann; M J Doenhoff
Journal:  Trans R Soc Trop Med Hyg       Date:  1985       Impact factor: 2.184

View more
  1 in total

Review 1.  Neopterin in Diagnosis and Monitoring of Infectious Diseases.

Authors:  Michael Eisenhut
Journal:  J Biomark       Date:  2013-12-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.